In this prospective observational study on patients with severe AKI treated via CVVHDF in seven ICUs, we reported that elevated urinary NGAL and plasma IL-6 at CVVHDF initiation were associated with poor prognosis. The gene discussed is LCN2; the disease is acute kidney injury.